Fahad Lwigale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fahad Lwigale has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mackline Hope
Research Kampala Central Region +256 Makerere University Infectious Diseases Institute
5 shared publications - Dathan Mirembe Byonanebye
Kampala Central Region 256 Makerere University Infectious Diseases Institute
4 shared publications - Andrew Kambugu
Makerere University
3 shared publications Francis Kakooza
3 shared publications- Francis Kakooza
Makerere University Infectious Diseases Institute, Kampala, Uganda
3 shared publications - Herman Mwanja
Infectious Diseases Institute, Kampala, Uganda
3 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 10, 665
Epidemiology of Bloodstream Bacterial Infections and Missed Opportunities to Detect and Respond to Possible Outbreaks Due to Drug-Resistant Bacteria in Hospitals in Uganda: A Review of Retrospective National AMR Surveillance Data 2020 to 2023
Background Antimicrobial resistance (AMR) poses a critical global health threat, with low- and middle-income countries (LMICs) facing systemic challenges in the detection and response to outbreaks of resistant pathogens. Despite Uganda establishing a national AMR surveillance system, there are no systems for the real-time detection of AMR outbreaks due to limited laboratory capacity, standardised protocols and data management systems. Methods This study involved a retrospective analysis of blood culture data collected from ten sentinel AMR surveillance sites (tertiary hospitals) across Uganda between October 2020 and December 2023 to evaluate AMR patterns, identify resistance alerts, and missed AMR outbreaks. Blood culture data from 2,572 patients were analysed using WHONET-SaTScan software to generate isolate listing summaries, identify resistance alerts of public health importance, and detect spatial-temporal clusters that signal potential outbreaks of resistant bacteria. Results Bacterial growth was observed in 17.1% (441/2,572) of blood samples. The key isolated pathogens included Staphylococcus aureus 19.1% (86/441), Coagulase-negative Staphylococci 34.7% (153/441), and Escherichia coli 7.5% (33/441). Critical AMR alerts included 13.6% (60/441) cases of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales and 3.6% (16/441) carbapenem-resistant isolates, alongside high-priority resistance mechanisms such as methicillin-resistant Staphylococcus aureus (15/441) and vancomycin-resistant Enterococci 1.4% (6/441). Spatial-temporal analysis revealed seven significant clusters (possible outbreaks) across three sites, including a 12-day Enterococcus species cluster in a paediatric ward and a multi-ward Staphylococcus aureus outbreak. Conclusions This study reveals a significant burden of drug-resistant bloodstream infections in Ugandan hospitals and shows that key outbreak signals and possible outbreaks went unnoticed. Strengthening surveillance with real-time alerts, better data use, and targeted responses is critical to controlling the spread of resistant bacteria in Uganda and similar settings.
- 10 December 2025
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 10, 665
Open AccessEpidemiology of Bloodstream Bacterial Infections and Missed Opportunities to Detect and Respond to Possible Outbreaks Due to Drug-Resistant Bacteria in Hospitals in Uganda: A Review of Retrospective National AMR Surveillance Data 2020 to 2023
Background Antimicrobial resistance (AMR) poses a critical global health threat, with low- and middle-income countries (LMICs) facing systemic challenges in the detection and response to outbreaks of resistant pathogens. Despite Uganda establishing a national AMR surveillance system, there are no systems for the real-time detection of AMR outbreaks due to limited laboratory capacity, standardised protocols and data management systems. Methods This study involved a retrospective analysis of blood culture data collected from ten sentinel AMR surveillance sites (tertiary hospitals) across Uganda between October 2020 and December 2023 to evaluate AMR patterns, identify resistance alerts, and missed AMR outbreaks. Blood culture data from 2,572 patients were analysed using WHONET-SaTScan software to generate isolate listing summaries, identify resistance alerts of public health importance, and detect spatial-temporal clusters that signal potential outbreaks of resistant bacteria. Results Bacterial growth was observed in 17.1% (441/2,572) of blood samples. The key isolated pathogens included Staphylococcus aureus 19.1% (86/441), Coagulase-negative Staphylococci 34.7% (153/441), and Escherichia coli 7.5% (33/441). Critical AMR alerts included 13.6% (60/441) cases of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales and 3.6% (16/441) carbapenem-resistant isolates, alongside high-priority resistance mechanisms such as methicillin-resistant Staphylococcus aureus (15/441) and vancomycin-resistant Enterococci 1.4% (6/441). Spatial-temporal analysis revealed seven significant clusters (possible outbreaks) across three sites, including a 12-day Enterococcus species cluster in a paediatric ward and a multi-ward Staphylococcus aureus outbreak. Conclusions This study reveals a significant burden of drug-resistant bloodstream infections in Ugandan hospitals and shows that key outbreak signals and possible outbreaks went unnoticed. Strengthening surveillance with real-time alerts, better data use, and targeted responses is critical to controlling the spread of resistant bacteria in Uganda and similar settings.
- Open Access
- 17 October 2025
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17  (5) , 132
Distribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020
Background: Gonorrhoea is a common sexually transmitted infection with serious health consequences if not well-treated. Resistance to common therapeutic agents and limited diagnostics further heighten its burden on sexual and reproductive health. This study determined the positivity level, spatial distribution and factors influencing test positivity for Neisseria gonorrhoeae in Kampala, Uganda. Methods: Clinical data and urethral swabs were primarily collected from men with urethritis at 10 high-volume surveillance facilities. Laboratory analysis followed conventional microbiology techniques. Statistical analysis was conducted using R 4.4.3. Results: Among 1663 participants, 923 (56%, 95% CI: 53–58%) tested positive for N. gonorrhoeae, with comparable levels in Kampala divisions. Co-positivity of HIV and N. gonorrhoeae ranged from 5–27%. At bivariable analysis, there was a lower risk of testing positive for N. gonorrhoeae among participants aged above 24 years. Individuals who never use condoms or infrequently use them were marginally at a higher risk for positivity compared to routine users. Only age was the independent predictor for positivity with N. gonorrhoeae (aPR = 0.93, 95% CI: 0.87–0.99, p-value = 0.017), with men aged above 24 years being less likely to test positive for N. gonorrhoeae. Conclusions: Spatial distribution of N. gonorrhoeae positivity in Kampala was found not to be significantly influenced by location in any of the five divisions. Public health interventions should be tailored to focus on the high-risk groups such as men aged below 25 years, incorporating targeted education and prevention programs, particularly emphasizing consistent condom use among sexually active individuals to improve sexual and reproductive health in Kampala and greater Uganda.
- 17 October 2025
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17  (5) , 132
Open AccessDistribution and Factors Associated with Neisseria gonorrhoeae Cases in Kampala, Uganda, 2016–2020
Background: Gonorrhoea is a common sexually transmitted infection with serious health consequences if not well-treated. Resistance to common therapeutic agents and limited diagnostics further heighten its burden on sexual and reproductive health. This study determined the positivity level, spatial distribution and factors influencing test positivity for Neisseria gonorrhoeae in Kampala, Uganda. Methods: Clinical data and urethral swabs were primarily collected from men with urethritis at 10 high-volume surveillance facilities. Laboratory analysis followed conventional microbiology techniques. Statistical analysis was conducted using R 4.4.3. Results: Among 1663 participants, 923 (56%, 95% CI: 53–58%) tested positive for N. gonorrhoeae, with comparable levels in Kampala divisions. Co-positivity of HIV and N. gonorrhoeae ranged from 5–27%. At bivariable analysis, there was a lower risk of testing positive for N. gonorrhoeae among participants aged above 24 years. Individuals who never use condoms or infrequently use them were marginally at a higher risk for positivity compared to routine users. Only age was the independent predictor for positivity with N. gonorrhoeae (aPR = 0.93, 95% CI: 0.87–0.99, p-value = 0.017), with men aged above 24 years being less likely to test positive for N. gonorrhoeae. Conclusions: Spatial distribution of N. gonorrhoeae positivity in Kampala was found not to be significantly influenced by location in any of the five divisions. Public health interventions should be tailored to focus on the high-risk groups such as men aged below 25 years, incorporating targeted education and prevention programs, particularly emphasizing consistent condom use among sexually active individuals to improve sexual and reproductive health in Kampala and greater Uganda.
- Open Access
- 28 February 2025
- Published by Microbiology Society
- p. 000874.v3
Antimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital in Uganda
Background: Bloodstream infections (BSIs) are common acute syndromes of variable origin with high chances for extreme health effects including death. Empirical therapy is usually employed to manage the BSIs despite the high resistance to the antibacterial agents used including cefriaxone and/or metronindazole. This study determined the aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods: This retrospective cross-sectional study involved analysis of data from all non-duplicate blood culture reports from 2019 to 2021. These were earlier generated using single set blood culture, conventional microbiology techniques and disc diffusion-based antimicrobial susceptibility testing (AST) guided by the Clinical and Laboratory Standards Institute (CLSI) guidelines. World Health Organization Network (WHONET) 2022 desktop software and Microsoft Excel were utilised for data analysis. Results: The 1364 reports showed a diagnostic yield of 6.8% (93/1364) and a 1.5%(21/1364) contamination rate. Overall, 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39/114 (34.2%). Polymicrobial growth existed in 4/1364(0.3%) cases. Staphylococcus aureus was mainly resistant to penicillin G (100%) and most susceptible to gentamicin (%S=74.1, 95% C.I:53.4-88.1). Escherichia coli and unspecified Coliforms together showed high resistance to ampicillin (87.5%) and third-generation cephalosporins (100%). The least resistance was to chloramphenicol and carbapenems. Conclusion: Staphylococcus aureus highly sensitive to gentamicin was the commonest cause of BSIs in this setting. Therefore, empirical management of suspected BSI cases in the region should include gentamicin. Use of Microbiology services including culture and sensitivity to guide targeted antimicrobial use and monitor resistance trends is required to strengthen antimicrobial stewardship.
- 28 February 2025
- Published by Microbiology Society
- p. 000874.v3
Open AccessAntimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital in Uganda
Background: Bloodstream infections (BSIs) are common acute syndromes of variable origin with high chances for extreme health effects including death. Empirical therapy is usually employed to manage the BSIs despite the high resistance to the antibacterial agents used including cefriaxone and/or metronindazole. This study determined the aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods: This retrospective cross-sectional study involved analysis of data from all non-duplicate blood culture reports from 2019 to 2021. These were earlier generated using single set blood culture, conventional microbiology techniques and disc diffusion-based antimicrobial susceptibility testing (AST) guided by the Clinical and Laboratory Standards Institute (CLSI) guidelines. World Health Organization Network (WHONET) 2022 desktop software and Microsoft Excel were utilised for data analysis. Results: The 1364 reports showed a diagnostic yield of 6.8% (93/1364) and a 1.5%(21/1364) contamination rate. Overall, 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39/114 (34.2%). Polymicrobial growth existed in 4/1364(0.3%) cases. Staphylococcus aureus was mainly resistant to penicillin G (100%) and most susceptible to gentamicin (%S=74.1, 95% C.I:53.4-88.1). Escherichia coli and unspecified Coliforms together showed high resistance to ampicillin (87.5%) and third-generation cephalosporins (100%). The least resistance was to chloramphenicol and carbapenems. Conclusion: Staphylococcus aureus highly sensitive to gentamicin was the commonest cause of BSIs in this setting. Therefore, empirical management of suspected BSI cases in the region should include gentamicin. Use of Microbiology services including culture and sensitivity to guide targeted antimicrobial use and monitor resistance trends is required to strengthen antimicrobial stewardship.
- Open Access
- 22 November 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 692
Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A scoping review
Introduction The World Health Organization global antimicrobial resistance surveillance system (GLASS) was rolled out in 2015 to guide antimicrobial resistance (AMR) surveillance. However, its implementation in Africa has not been fully evaluated. We conducted a scoping review to establish the progress of implementing the WHO 2015 GLASS manual in Africa. Methods We used MeSH terms to comprehensively search electronic databases (MEDLINE and Embase) for articles from Africa published in English between January 2016 and December 2023. The Arksey and O'Malley's methodological framework for scoping reviews was employed. Data were collected on compliance with WHO GLASS recommendations for AMR surveillance-priority samples, pathogens, and pathogen-antibiotic combinations and analysed using Microsoft Excel. Results Overall, 13,185 articles were identified. 7,409 were duplicates, and 5,141 articles were excluded based on titles and abstracts. 609 full-text articles were reviewed, and 147 were selected for data extraction. Of the 147 selected articles, 78.9% had been published between 2020 and 2023; 57.8% were from Eastern Africa. 93.9% of articles were on cross-sectional studies. 96.6% included only one priority sample type; blood (n=56), urine (n=64), and stool (n=22). Of the 60 articles that focused on blood as a priority sample type, 71.7%, 68.3%, 68.3%, 36.7%, 30%, and 10% reported recovery of Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Salmonella species and Streptococcus pneumoniae, respectively. Salmonella and Shigella species were reported to have been recovered from 91.3% and 73.9% of the 23 articles that focused on stool. E. coli and K. pneumoniae recoveries were also reported from 94.2% and 68.1% of the 69 articles that focused on urine. No article in this review reported having tested all the recommended WHO GLASS pathogen-antibiotic combinations for specific pathogens. Conclusion Progress has been made in implementing the GLASS recommendations in Africa, but adoption varies across countries limiting standardisation and comparability of data.
- 22 November 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 692
Open AccessProgress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A scoping review
Introduction The World Health Organization global antimicrobial resistance surveillance system (GLASS) was rolled out in 2015 to guide antimicrobial resistance (AMR) surveillance. However, its implementation in Africa has not been fully evaluated. We conducted a scoping review to establish the progress of implementing the WHO 2015 GLASS manual in Africa. Methods We used MeSH terms to comprehensively search electronic databases (MEDLINE and Embase) for articles from Africa published in English between January 2016 and December 2023. The Arksey and O'Malley's methodological framework for scoping reviews was employed. Data were collected on compliance with WHO GLASS recommendations for AMR surveillance-priority samples, pathogens, and pathogen-antibiotic combinations and analysed using Microsoft Excel. Results Overall, 13,185 articles were identified. 7,409 were duplicates, and 5,141 articles were excluded based on titles and abstracts. 609 full-text articles were reviewed, and 147 were selected for data extraction. Of the 147 selected articles, 78.9% had been published between 2020 and 2023; 57.8% were from Eastern Africa. 93.9% of articles were on cross-sectional studies. 96.6% included only one priority sample type; blood (n=56), urine (n=64), and stool (n=22). Of the 60 articles that focused on blood as a priority sample type, 71.7%, 68.3%, 68.3%, 36.7%, 30%, and 10% reported recovery of Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Salmonella species and Streptococcus pneumoniae, respectively. Salmonella and Shigella species were reported to have been recovered from 91.3% and 73.9% of the 23 articles that focused on stool. E. coli and K. pneumoniae recoveries were also reported from 94.2% and 68.1% of the 69 articles that focused on urine. No article in this review reported having tested all the recommended WHO GLASS pathogen-antibiotic combinations for specific pathogens. Conclusion Progress has been made in implementing the GLASS recommendations in Africa, but adoption varies across countries limiting standardisation and comparability of data.
- Open Access
- 15 November 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13  (1) , e58140
Progress of Implementation of World Health Organization Global Antimicrobial Resistance Surveillance System Recommendations on Priority Pathogen-Antibiotic Sensitivity Testing in Africa: Protocol for a Scoping Review
Background: Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. Objective: The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. Methods: Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. Results: The study results are expected in August 2024. Conclusions: To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. International Registered Report Identifier (IRRID): PRR1-10.2196/58140
- 15 November 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13  (1) , e58140
Open AccessProgress of Implementation of World Health Organization Global Antimicrobial Resistance Surveillance System Recommendations on Priority Pathogen-Antibiotic Sensitivity Testing in Africa: Protocol for a Scoping Review
Background: Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. Objective: The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. Methods: Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. Results: The study results are expected in August 2024. Conclusions: To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. International Registered Report Identifier (IRRID): PRR1-10.2196/58140
- Open Access
- 2 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4  (8) , e0003582
Prevalence, resistance profiles and factors associated with skin and soft-tissue infections at Jinja regional referral hospital: A retrospective study
Skin and soft-tissue infections (SSTI) are common cases of hospital-acquired infections with aetiological agents exhibiting antimicrobial resistance (AMR). This is a global public health predicament responsible for a high burden of infectious diseases and threatens the achievement of Sustainable Development Goals (SDGs), especially in Low- and Middle-Income countries (LMICs). This study determined the prevalence of SSTI, proportion of laboratory-investigated cases, AMR-profiles, and factors associated with SSTI and multi-drug resistance (MDR). This was based on records of patients suspected of SSTI for the period of 2019–2021 at Jinja Regional Referral Hospital. The analysis involved 268 randomly selected patient reports using WHONET 2022 and Stata 17 at the 95% confidence level. The prevalence of SSTI was 66.4%. Cases that involved laboratory testing were 14.1%. Staphylococcus aureus (n = 51) was the most isolated organism. MDR pathogens explained 47% of infections. Methicillin-resistant Staphylococcus aureus (MRSA) was up to 44%. In addition, 61% of Gram-negatives had the potential to produce extended-spectrum beta-lactamases (ESBL), while 27% were non-susceptible to carbapenems. Ward of admission was significantly associated with infection (aPR = 1.78, 95% CI: 1.00–3.18, p-value = 0.04). Age category (19–35) was an independent predictor for MDR infections (aPR = 2.30, 95%CI:1.02–5.23, p-value = 0.04). The prevalence of SSTI is high with MDR pathogens responsible for almost half of the infections. Gentamicin and ciprofloxacin can be considered for empirical management of strictly emergency SSTI cases suspected of Staphylococcus aureus. Given the high resistance observed, laboratory-based diagnosis should be increased to use the most appropriate treatment. Infection Prevention and Control (IPC) strategies should be heightened to reduce the prevalence of SSTI. Recognizing SSTI under the Global Antimicrobial resistance Surveillance System (GLASS) would lead to improved preparedness and response to AMR.
- 2 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4  (8) , e0003582
Open AccessPrevalence, resistance profiles and factors associated with skin and soft-tissue infections at Jinja regional referral hospital: A retrospective study
Skin and soft-tissue infections (SSTI) are common cases of hospital-acquired infections with aetiological agents exhibiting antimicrobial resistance (AMR). This is a global public health predicament responsible for a high burden of infectious diseases and threatens the achievement of Sustainable Development Goals (SDGs), especially in Low- and Middle-Income countries (LMICs). This study determined the prevalence of SSTI, proportion of laboratory-investigated cases, AMR-profiles, and factors associated with SSTI and multi-drug resistance (MDR). This was based on records of patients suspected of SSTI for the period of 2019–2021 at Jinja Regional Referral Hospital. The analysis involved 268 randomly selected patient reports using WHONET 2022 and Stata 17 at the 95% confidence level. The prevalence of SSTI was 66.4%. Cases that involved laboratory testing were 14.1%. Staphylococcus aureus (n = 51) was the most isolated organism. MDR pathogens explained 47% of infections. Methicillin-resistant Staphylococcus aureus (MRSA) was up to 44%. In addition, 61% of Gram-negatives had the potential to produce extended-spectrum beta-lactamases (ESBL), while 27% were non-susceptible to carbapenems. Ward of admission was significantly associated with infection (aPR = 1.78, 95% CI: 1.00–3.18, p-value = 0.04). Age category (19–35) was an independent predictor for MDR infections (aPR = 2.30, 95%CI:1.02–5.23, p-value = 0.04). The prevalence of SSTI is high with MDR pathogens responsible for almost half of the infections. Gentamicin and ciprofloxacin can be considered for empirical management of strictly emergency SSTI cases suspected of Staphylococcus aureus. Given the high resistance observed, laboratory-based diagnosis should be increased to use the most appropriate treatment. Infection Prevention and Control (IPC) strategies should be heightened to reduce the prevalence of SSTI. Recognizing SSTI under the Global Antimicrobial resistance Surveillance System (GLASS) would lead to improved preparedness and response to AMR.
- Open Access
- 1 August 2024
- Published by Microbiology Society
- p. 000874.v2
Antimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital: A cross-sectional study
Background Bloodstream infections are common acute syndromes of variable origin with high chances for extreme health effects including death. This underscores the essence for their quick management to expedite better outcomes. In this study settings, therapy is predominantly empirical using majorly cefriaxone and/or metronindazole. Agents for empirical therapy are liable to antimicrobial resistance and their choice ought to be routinely guided by microbiology laboratory data. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods: The analysis involved all non-duplicate blood culture reports from 2019 to 2021 using World Health Organization Network (WHONET) 2022 desktop software and Microsoft Excel. Results: The 1364 reports showed a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to penicillin G(100%) but most susceptible to gentamicin(%S=74.1, 95%C.I:53.4-88.1). Escherichia coli and unspecified Coliforms together showed high resistance to ampicillin(87.5%) and third-generation cephalosporins(100%). The least resistance was to chloramphenicol and carbapenems. Conclusion: As the most frequent explanatory for septicaemia, S. aureus suspected cases in this region could have higher success with gentamicin involved in the empirical therapy combination for their management. The heightened resistance against ceftriaxone requires its limited use. Microbiology services should be routinely utilized to guide targeted antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
- 1 August 2024
- Published by Microbiology Society
- p. 000874.v2
Open AccessAntimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital: A cross-sectional study
Background Bloodstream infections are common acute syndromes of variable origin with high chances for extreme health effects including death. This underscores the essence for their quick management to expedite better outcomes. In this study settings, therapy is predominantly empirical using majorly cefriaxone and/or metronindazole. Agents for empirical therapy are liable to antimicrobial resistance and their choice ought to be routinely guided by microbiology laboratory data. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods: The analysis involved all non-duplicate blood culture reports from 2019 to 2021 using World Health Organization Network (WHONET) 2022 desktop software and Microsoft Excel. Results: The 1364 reports showed a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to penicillin G(100%) but most susceptible to gentamicin(%S=74.1, 95%C.I:53.4-88.1). Escherichia coli and unspecified Coliforms together showed high resistance to ampicillin(87.5%) and third-generation cephalosporins(100%). The least resistance was to chloramphenicol and carbapenems. Conclusion: As the most frequent explanatory for septicaemia, S. aureus suspected cases in this region could have higher success with gentamicin involved in the empirical therapy combination for their management. The heightened resistance against ceftriaxone requires its limited use. Microbiology services should be routinely utilized to guide targeted antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
- Open Access
- 1 July 2024
- Published by Microbiology Society
- p. 000874.v1
Antimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital: A cross-sectional study
Purpose This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods The analysis involved all non-duplicate blood culture reports from 2019 to 2021 using World Health Organization Network (WHONET 2022) desktop software. Results The 1364 reports showed a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to penicillin G but most susceptible to gentamicin. Escherichia coli and unspecified coliforms together showed high resistance to ampicillin(87.5%) and third-generation cephalosporins(100%). The least resistance was to chloramphenicol and carbapenems. Conclusion Empirical management of suspected sepsis cases by S. aureus in this region could have higher success with gentamicin involved in the therapy combination. Microbiology services should be routinely utilized to guide targeted antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
- 1 July 2024
- Published by Microbiology Society
- p. 000874.v1
Open AccessAntimicrobial resistance patterns of isolates from bloodstream infections at Jinja Regional Referral Hospital: A cross-sectional study
Purpose This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-central Uganda. Patients and methods The analysis involved all non-duplicate blood culture reports from 2019 to 2021 using World Health Organization Network (WHONET 2022) desktop software. Results The 1364 reports showed a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital-acquired and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to penicillin G but most susceptible to gentamicin. Escherichia coli and unspecified coliforms together showed high resistance to ampicillin(87.5%) and third-generation cephalosporins(100%). The least resistance was to chloramphenicol and carbapenems. Conclusion Empirical management of suspected sepsis cases by S. aureus in this region could have higher success with gentamicin involved in the therapy combination. Microbiology services should be routinely utilized to guide targeted antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
- Open Access
- 7 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Progress of Implementation of World Health Organization Global Antimicrobial Resistance Surveillance System Recommendations on Priority Pathogen-Antibiotic Sensitivity Testing in Africa: Protocol for a Scoping Review (Preprint)
BACKGROUND Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. OBJECTIVE The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. METHODS Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. RESULTS The study results are expected in August 2024. CONCLUSIONS To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/58140
- 7 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessProgress of Implementation of World Health Organization Global Antimicrobial Resistance Surveillance System Recommendations on Priority Pathogen-Antibiotic Sensitivity Testing in Africa: Protocol for a Scoping Review (Preprint)
BACKGROUND Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. OBJECTIVE The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. METHODS Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. RESULTS The study results are expected in August 2024. CONCLUSIONS To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/58140
- Open Access
Antimicrobial resistance patterns of bacterial isolates from bloodstream infections at Jinja regional referral hospital: A cross-sectional study
Introduction: Bloodstream infections are a commonly encountered clinical syndrome of public health concern with variable epidemiology. The characteristic of resistance to multiple antibiotics by their etiologic agents has limited the options for empirical sepsis case management. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-Central Uganda. Materials and methods: This retrospective study involved analysis of all non-duplicate blood culture reports from 2019 to 2021. The frequency and percentage of significant pathogenic organisms and contaminants were calculated. Positivity distribution including infection sources was determined. World Health Organization Network (WHONET) 2022 desktop software was used for antimicrobial susceptibility data analysis. Results: The 1364 participants had a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Gram-negatives mainly included unspecified Coliforms 12(10.5%), and E. coli 10(8.8%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to Penicillin G (100%), Cefoxitin (60%), and Erythromycin (52.2%). Both Escherichia coli and unspecified coliforms showed high resistance to Ampicillin (87.5%) and third-generation Cephalosporins (100%). The least resistance was to Chloramphenicol and Carbapenems. Conclusion: BSIs are mainly due to Gram-positive bacteria. Suspected sepsis cases by S. aureus in this region can be empirically managed using Gentamicin. Microbiology services should be routinely utilized to guide antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.
Open AccessAntimicrobial resistance patterns of bacterial isolates from bloodstream infections at Jinja regional referral hospital: A cross-sectional study
Introduction: Bloodstream infections are a commonly encountered clinical syndrome of public health concern with variable epidemiology. The characteristic of resistance to multiple antibiotics by their etiologic agents has limited the options for empirical sepsis case management. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-Central Uganda. Materials and methods: This retrospective study involved analysis of all non-duplicate blood culture reports from 2019 to 2021. The frequency and percentage of significant pathogenic organisms and contaminants were calculated. Positivity distribution including infection sources was determined. World Health Organization Network (WHONET) 2022 desktop software was used for antimicrobial susceptibility data analysis. Results: The 1364 participants had a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Gram-negatives mainly included unspecified Coliforms 12(10.5%), and E. coli 10(8.8%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to Penicillin G (100%), Cefoxitin (60%), and Erythromycin (52.2%). Both Escherichia coli and unspecified coliforms showed high resistance to Ampicillin (87.5%) and third-generation Cephalosporins (100%). The least resistance was to Chloramphenicol and Carbapenems. Conclusion: BSIs are mainly due to Gram-positive bacteria. Suspected sepsis cases by S. aureus in this region can be empirically managed using Gentamicin. Microbiology services should be routinely utilized to guide antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.